Clinical utility of nucleic acid amplification testing for detection of sexually transmitted infections in women with symptomatic bacterial vaginosis and vulvovaginal candidiasis identified by conventional versus molecular diagnoses.

Damon Getman¹, Arlene C Seña², Ashley Nenninger¹, Jane R Schwebke³

¹Hologic, Inc., San Diego, California, USA.

²University of North Carolina, Chapel Hill, North Carolina, USA.

³University of Alabama at Birmingham, Birmingham, Alabama, USA.

PubMed DOI

Abstract

Numerous studies describe increased rates of sexually transmitted infections (STIs) in women with symptomatic vaginitis from various causes. We present a comparative analysis of the diagnostic utility of STI nucleic acid amplification testing (NAAT) for Trichomonas vaginalis (TV), Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Mycoplasma genitalium (MG) in 1,039 women with symptomatic…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.